Breakeven Is Near for Tomocube, Inc. (KOSDAQ:475960)

Tomocube, Inc. (KOSDAQ:475960) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. With the latest financial year loss of ₩4.8b and a trailing-twelve-month loss of ₩3.4b, the ₩398b market-cap company alleviated its loss by moving closer towards its target of breakeven. Many investors are wondering about the rate at which Tomocube will turn a profit, with the big question being “when will the company breakeven?” Below we will provide a high-level summary of the industry analysts’ expectations for the company.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Expectations from some of the South Korean Medical Equipment analysts is that Tomocube is on the verge of breakeven. They anticipate the company to incur a final loss in 2025, before generating positive profits of ₩3.6b in 2026. So, the company is predicted to breakeven approximately a year from now or less! At what rate will the company have to grow in order to realise the consensus estimates forecasting breakeven in under 12 months? Using a line of best fit, we calculated an average annual growth rate of 144%, which is extremely buoyant. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.

Underlying developments driving Tomocube's growth isn’t the focus of this broad overview, however, bear in mind that typically a high growth rate is not out of the ordinary, particularly when a company is in a period of investment.

View our latest analysis for Tomocube

One thing we’d like to point out is that Tomocube has no debt on its balance sheet, which is quite unusual for a cash-burning growth company, which typically has high debt relative to its equity. This means that the company has been operating purely on its equity investment and has no debt burden. This aspect reduces the risk around investing in the loss-making company.

Next Steps:

There are too many aspects of Tomocube to cover in one brief article, but the key fundamentals for the company can all be found in one place – Tomocube's company page on Simply Wall St. We've also compiled a list of pertinent aspects you should further examine:

1. Valuation: What is Tomocube worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Tomocube is currently mispriced by the market.
2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Tomocube’s board and the CEO’s background.
3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.